Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · Real-Time Price · USD

20.96

-0.68 (-3.14%)

At close: Feb 27, 2026, 4:00 PM EST

20.80

-0.16 (-0.76%)

After-hours: Feb 27, 2026, 7:55 PM EST

Apellis Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,004	781.37	396.59	75.42	66.56
Revenue Growth (YoY)	28.46%	97.02%	425.83%	13.31%	-73.44%
Cost of Revenue	398.09	445.29	412.9	392.87	426.07
Gross Profit	605.69	336.07	-16.31	-317.45	-359.51
Selling, General & Admin	550.27	501.05	500.82	277.16	176.77
Operating Expenses	550.27	501.05	500.82	277.16	176.77
Operating Income	55.43	-164.98	-517.12	-594.61	-536.28
Interest Expense	-44.33	-40.39	-29.58	-32.63	-13.24
Interest & Investment Income	13.14	12.77	20.93	8.91	0.42
Other Non Operating Income (Expenses)	-0.13	-2.17	-0.73	-0.29	-96.31
EBT Excluding Unusual Items	24.11	-194.77	-526.5	-618.61	-645.41
Other Unusual Items	-	-1.95	-	-32.89	-100.59
Pretax Income	24.11	-196.72	-526.5	-651.5	-746
Income Tax Expense	1.72	1.16	2.13	0.67	0.35
Net Income	22.39	-197.88	-528.63	-652.17	-746.35
Net Income to Common	22.39	-197.88	-528.63	-652.17	-746.35
Shares Outstanding (Basic)	126	124	119	106	84
Shares Outstanding (Diluted)	130	124	119	106	84
Shares Change (YoY)	4.80%	4.40%	11.84%	25.70%	12.32%
EPS (Basic)	0.18	-1.60	-4.45	-6.15	-8.84
EPS (Diluted)	0.17	-1.60	-4.45	-6.15	-8.84
Free Cash Flow	45.01	-88.27	-595.51	-515.27	-564.23
Free Cash Flow Per Share	0.35	-0.71	-5.02	-4.86	-6.68
Gross Margin	60.34%	43.01%	-4.11%	-	-
Operating Margin	5.52%	-21.11%	-130.39%	-788.38%	-805.67%
Profit Margin	2.23%	-25.32%	-133.29%	-864.70%	-1121.28%
Free Cash Flow Margin	4.48%	-11.30%	-150.16%	-683.18%	-847.66%
EBITDA	56.99	-163.18	-515.34	-593.06	-534.9
EBITDA Margin	5.68%	-20.88%	-129.94%	-	-
D&A For EBITDA	1.56	1.8	1.78	1.55	1.38
EBIT	55.43	-164.98	-517.12	-594.61	-536.28
EBIT Margin	5.52%	-21.11%	-130.39%	-	-
Effective Tax Rate	7.14%	-	-	-	-
Revenue as Reported	1,004	781.37	396.59	75.42	66.56

Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q